THE TAMILNADU CHEMISTS & DRUGGISTS ASSOCIATION (REGD.
)
(Affiliated to All India Organisation of Chemists & Druggists)
D-36, 8th Floor, `D’ Block, Halls Towers, 33, Halls Road, Chennai - 600 008.
E-mail : tncda_sangam@yahoo.co.in Website : www.tncda.com
President:
K. MANOHARAN D.Pharm.,
M/s. Thillai Medicals,
No.29-B, 10th Cross, Main Road,
Thillai Nagar, Trichy - 620 018.
Ph: 0431-2762555. Mobile: 94431 76555
E-mail: manoharan.k2222@gmail.com
Chairman,
Tamilnadu Chemists & Druggists
Welfare Charitable Trust
KR.SENTHIL VADIVEL
Salem, Cell: 98427 26047
Patron
K.R. CHINNAIAH CHETTIAR
Villuppuram, Cell: 9952921010
Organising Secretary
P. ANBALAGAN
Namakkal, Cell: 80980 20244
Chairman, Wholesale Wing
A. BHASKARAN
Trichy, Cell: 94434 77840
Chairman, Co-ordination Comm.
S.A. RAMESH
Chennai, Cell: 98400 50518
Chairman, Retailwing
ANNAM THIRUNAVUKARASU
Kovai, 97886 02345
Chairman - Constitution Com.
K. SHANMUGAM
Tiruvannamalai, Cell: 9361111974
Vice President
A. KARUPPIAH
Kovai, Cell: 94430 37017
Vice President
V.M. KADER MYDEEN
Tirunelveli, Cell: 98420 09964
Vice President
C. MANOHAR
Madurai, Cell: 98424 64021
Vice President
P. THIRULOGACHANDAR
Chennai, Cell: 98408 62882
Joint Secretary
R. THIRUNAVUKARASU
Dharmapuri / Krishnagiri
94885 64343
TAMILNADU CHEMISTS
Phone : 2819 1522
Hon. General Secretary: Treasurer:
K.K. SELVAN B.Sc., S. ELANGOVAN M.Pharm., M.B.A.
M/s.Sharadha Medicals M/s. LEVISER IMPEX,
8/C, Omalur Main Road, Four Road, Salem - 9. No. 4, West Club Road,
Ph: 0427-235 3353, 403 1318 Shenoy Nagar, Chennai - 600 030.
Mobile : 93609 99909 Mobile: 98843 02901, 95660 51684
E-mail: kkselvan72@gmail.com E-mail: leviserpharma@gmail.com
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567 Chairman,
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567 Auditing Committee
CONTENTS
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567
P. STEPHEN
Tirunelveli, Cell: 99407 79222
1. EDITORIAL Convenor, Trade Reforms &
Continuous Education
2. GENERAL SECRETARY’S DESK S. SENTHIL KUMAR
Erode, Cell: 98427 39233
3. DISTRICT NEWS Chairman, Arbitration Comm.
A.T. KUMAR
4. PRODUCT INFORMATION Kanyakumar, Cell: 94431 23370
PRO
5. MISCELLANEOUS R. GOVINDARAJ
Perambalur, Cell: 94431 55116
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567 Chairman, Trade Affairs Comm.
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567 G. SIVAM
TARIFF
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567 Thanjavur, Cell: 99422 88588
Chairman, Retail Protection Force-
FOR ADVERTISEMENTS PER ISSUE P.F.I. RAJA
Chengalpattu, Cell: 99443 54806
Size : 18.5 cms x 24.5 cms Secretary, Pharmacists Association
J.VENKATA SUNDARAM
Fourth Cover : Rs. 20,000/- Cuddalore, Cell: 99944 48464
Chairman,
Inside Cover Page : Rs. 15,000/- Retail Welfare Committee
G. VENKATESAN
Full Page : Rs. 10,000/- Kanchi-Chengai, 94434 67035
Chairman,
20% Discount on your yearly contract. Members Welfare Committee
A. SRINIVASAGAN
“Form-VV Price List Publication” Virudhunagar, Cell: 94435 44790
charges Rs. 5,000/- per product / strength. Deputy Secretary
S. ARUL RAJA
(Details of strength, packing, composition GST % etc. to be specified) Sivagangai, Cell: 94430 92258
Deputy Secretary
Total Circulation : 20,000 Copies M. ABDUL JAFFAR
Pudukottai, Cell: 80985 32444
Convenor, Trade & Indusry
Editor : K.K. SELVAN, Mobile: 93609 99909 J. RAMESH BABU
Dindigul, Cell: 98421 23620
3 AUGUST SEPTEMBER 2020
 jiya§f«
ïªâa Rjªâu¤ âUehŸ
m‹òilp®! tz¡f«.
ekJ ghuj njr« ãÇ£oZ fhyÅ Mâ¡f¤âÈUªJ ÉLjiy bg‰W 72 M©LfŸ
cU©nlho É£lJ. 74tJ Rjªâu âd ÉHhit bfh©lhL« jUz¤âš ïU¡»‹nwh«.
“v‹W jÂí« ïªj Rjªâu jhf«
v‹W koí« v§fŸ moikÆ‹ nkhf«”
v‹W ghuâ vGâdh‹. Rjªâujhf« Ô®ªJ É£lJ. Mdhš moikÆ‹ nkhf« KoªJ
É£ljh? xU nfŸÉ¡F¿ahfnt ïU¡»wJ. ï‹iwa ïisP®fS¡F ïªâahÉ‹ Rjªâu
âd« MfÞ£ 15 v‹gJ e‹F bjÇí«. vÅD« 1947¡F K‹ ïªâahÉ‹ Rjªâu âdkhdJ
#dtÇ 26 v‹gJ v¤jid ngU¡F bjÇí«? v‹dJ, 1947¡F K‹ Rjªâu âdkh? v‹d
FH¥ò»Ö®fŸ v‹W nf£»‹Ö®fsh? bjhl®ªJ goí§fŸ. 17« ü‰wh©oš t®¤jf« brŒa
tªj tÂf®fŸ gy® ïªâahÉ‹ bršt¢ brÊ¥igí« ïa‰if ts¤ijí« f©L ãuĤJ
Ëwh®fŸ. âiu flnyhoí« âuÉa« njoa ïªâa®fŸ ït®fŸ t®¤jf« brŒtj‰fhf¤
jhnd tªâU¡»wh®fŸ ït®fnshL t®¤jf« bjhl®òfis ts®¤J¡ bfh©ld®. Mdhš
mªj fat®fS¡F t®¤jf« v‹gJ k£L« nghjÉšiy. mijí« jh©o ïªj eh£oDila
bršt§fisbašyh« bfhŸis bfh©L bršy nt©L« v‹w nguhir tªJ É£lJ.
mjdo¥gilÆš »H¡»ªâa f«bgÅ v‹w x‹iw ÃWÉ mj‹ _ykhf gšntWÉjkhd
FWÃy k‹d®fSl‹ ngu« ngá mªj Ãy§fËš k£LkšyhJ m§FŸs gšntW
cÇikfisí« rhrd« brŒJ bfh©ld®. g§fhË¢ r©ilfshš ãÇîg£L¥ nghÆUªj
ghuj njr¤â‹ ghisa¡fhu®fisí«, FWÃy k‹d®fisí« j§fŸ tr¥gL¤â cwtho¡
bfL¤J xU rh«uh{a¤ij cUth¡»dh®fŸ. xU fhy f£l¤âš xU t®¤jf ÃWtd¤jhš
ïªj eh£oid Ms KoahJ v‹w Ãiy tªjîl‹ ãÇ£oZ rh«uh{a¤âl« x¥gil¤jh®fŸ.
ãÇ£oZ munrh, ïªj eh£oid M£á brŒtj‰F¥ ãuâ gydhf Vuhskhd bršt§fis
炙UªJ bfhŸisao¤J¢ br‹wJ. mJ k£LkšyhJ kj kh‰w§fis¢ brŒJ ïªj eh£o‹
fyhrhu¤ij fšÉ Kiwia xʤjJ. ïªj eh£L k¡fË‹ j‹d«ã¡ifiaí« Ra¢rh®ò¤
j‹ikiaí« xʤjJ. 炙UªJ y£r¡fz¡fhndhiu moikfshf¡ TÈfshf M¥Ç¡fh
MÞânuÈah, ïy§if, knyáah ngh‹w ehLfS¡F f¥gš f¥gyhf V‰¿ mD¥ãanjhL
炙U¥nghiuí« Ra áªjida‰wt®fshŒ kh‰¿ mt®fS¡F nt©oa FkhÞjh
c¤nahf« gh®¡f¡ Toat®fshf cUth¡f bk¡fhny fšÉ¤ â£l« v‹w x‹¿id
mKšgL¤âaJ. ïªj yh®£ bk¡fhny v‹gt® 1930fËš ïªâah tªJ ïªâahit xU
Fil¡Ñœ Ms nt©LbkÅš v‹d brŒa nt©L« v‹W MŒî brŒjh®. mªj MŒÉ‹
mo¥gilÆš 炙yhªJ ghuhSk‹w¤âš xU m¿¡if jh¡fš brŒjh®. “eh‹ ïªâah
KGtJ« R‰¿ tªJ É£nl‹. (ït® ï§F ïªâah v‹W F¿¥ãLtJ ï‹iwa ïªâah,
ïy§if, g§fshnjZ, gh»Þjh‹ v‹W mid¤J ehLfisí« cŸsl¡»ajhF«. ïªj
njr¤âš xU ã¢ir¡fhuidnah, âUlidnah eh‹ gh®¡fÉšiy. mªj msî¡F ïªj
njr¤âš bršt¢ brÊ¥ò ïU¡»‹wJ. ïªj njr¤ij eh« xU ehS« moik bfhŸtJ v‹gJ
ïayhj fhÇa«. m¥go mij¢ brŒa nt©Lbk‹whš ïªj njr¤âDila
fyh¢rhu¤ijí«, g©gh£ilí« fšÉ Kiwiaí« kh‰¿aik¡f nt©L«. v¥bghGJ
ït®fŸ j§fsJ fyh¢rhu« rÇÆšiy. j§fsJ g©ghL, ehfßf« rÇÆšiy v‹W
v©Q»‹wh®fnsh, v¥bghGJ M§»y¤âš brhšy¥g£l mid¤J« ca®thdJ v‹W
fUJ»wh®fnsh m¥bghGJ ït®fŸ ek¡F KG moikfsh» ÉLth®fŸ. ïij¢

TAMILNADU CHEMISTS 4 AUGUST SEPTEMBER 2020

brŒtj‰F ït®fSila fšÉ Kiwia kh‰¿ mik¡f nt©L«” v‹»wJ mªj
m¿¡if. ïªj m¿¡ifÆ‹ mo¥gilÆš jh‹ bk¡fhny fšÉ¤ â£l« v‹w â£l«
mkšgL¤j¥g£lJ. mj‹ fhuzkhfnt ïªj eh£ony eh« mJtiu brŒJ tªj
mid¤J« jtW v‹w fU¤J Éij¡f¥g£lJ. ekJ g©ghL, ehfÇf« mid¤Jnk
ÑHhdJ M§»nya®fSila ehfÇfK« g©ghL« nkyhdJ v‹w Éõ Éij
C‹w¥g£lJ. ïj‹ fhuzkhfnt ïªâa®fŸ j§fSila ÉŠPhd«, M‹Ûf«, thd
rhÞâu«, f£ol¡fiy, Étrha¡fiy ngh‹w mid¤ijí« kwªjd®. bjh‹W bjh£L
ïUªJ tªj gšntWÉjkhd m¿Éid m¿î¥ bgh¡»õ¤ij ïHªjd®. kd¥ghl¡ fšÉ
Kiw¡F kh¿, mt®fŸ brh‹dijbašyh« c©ik v‹W e«ã FkhÞjh¡fshf
Mdh®fŸ. ïUªjnghJ« 1947-š Rjªâu« tªJÉ£lnj mj‹ ãwfhtJ ïªj¡ fšÉ
Kiwia kh‰¿ ïU¡fyhnk v‹w c§fsJ nfŸÉ vd¡F¥ òÇ»‹wJ. vÅD« mªj¡
nfŸÉ¡fhd Éilia k‰bwhU f£LiuÆš jU»‹nw‹.
M§»nya®fË‹ Ru©lY« ml¡F Kiwí« mâfkh»¡ bfh©nl nghdJ. áW áW
òu£áfŸ bto¡f¤ bjhl§»d. óȤ njt‹, kUJ rnfhju®fŸ ngh‹wt®fŸ v⮡f¤
Jªjd®. jhŒ k©Â‹ ÛJ g‰W¡ bfh©l Vuhskhdt®fŸ mªÃa Mâ¡f¤ij
v⮤J òu£á brŒa Mu«ã¤jd®. M§fh§nf áW áW msÉš elªj ïªj òu£áfS¡F
všyh« kFl« it¤jh‰nghy 1857M« M©L eilbg‰w á¥ghŒ fyf« ïªâahÉ‹ Kjš
Rjªâu¥ ngh® v‹W t®Â¡f¥gL»wJ. ïªj Rauh{a« v§fŸ ãw¥òÇik v‹w Fuš X§»
xÈ¡f¤ bjhl§» ït®fŸ všyh« x‹W nr®¤J fh§»uÞ ngÇa¡f« 1885 M« M©L
Mu«ã¡f¥g£lJ. mf©L ÉǪj m‹iwa ghuj njr¤âš M§fh§nf Rjªâu¥
nghuh£l§fŸ elªJ bfh©oUªjd. 1915M« M©L eilbg‰w Kjš cyf¥ngh®
fhuzkhf Rjªâu¥ nghuh£l¤âš xU bjhŒî V‰g£lJ. Kjš cyf¥ nghU¡F¥ ã‹dnu
ãÇ£oZ Vfhâg¤âa« r‰nw M£l« Jt§»aJ. mjdhš uîy£ r£l« v‹w xU
ml¡FKiw¢ r£l¤ij ãw¥ã¤J ïªâahÉid ml¡» M©L tªjh®fŸ. nkhf‹jhÞ
fu«rª¤ fhªâ, ghyf§fhju ây¡, nejhÍ RghZ rªâunghÞ, f¥gnyh£oa jÄH‹ t.c.
áj«gudh®, R¥ãukÂa áth, R¥ãukÂa ghuâ nghd‰ gy njrg¡j®fshš ïªj Rjªâu¥
nghuh£l« tY¥bg‰wJ. Kjyh« cyf¥nghU¡F ã‹ò k¡fŸ g§nf‰F« M£áÆid
mkšgL¤j M§»y murh§f« x¥ò¡ bfh©L nj®jšfis el¤âaJ. m¥nghJ fh§»uÞ
ngÇa¡f« bgU«gh‹ikahd khÃy§fËš nj®jÈš bt‰¿ bg‰W M£á mik¤jJ.
ïUªjhY« óuz Rjªâu« x‹nw j§fsJ F¿¡nfhŸ v‹W yhT® kheh£oš ãufld¥
gL¤j¥g£lJ. mjdo¥gilÆš #dtÇ 26« njâÆid Rjªâu âdkhf m¿É¤jJ.
m‹¿ÈUªJ jh‹ x¤JiHahik ïa¡f« Jt¡f¥ bg‰wJ (Civil Disobedience). 1930š ïUªJ
1946 tiu #dtÇ 26« njâna ïªâa Rjªâu âdkhf mDrÇ¡f¥g£L tªjJ. ïªj ehis¤
nj®ªbjL¡f ï‹bdhU K¡»a fhuz« 1565« M©L, ïnj #dtÇ 26š jh‹ jÈ¡nfh£lh
(ï‹iwa f®ehlfhÉš cŸsJ) nghÇš jøz Ršjh‹fŸ filá ïªJ uh{akhd É#a
efu¥ nguuá‹ uhk uhaiu¤ njh‰fo¤J, Kfyha rh«uh{a¤ij ÃWÉa ehshF«. mj‹
ã‹d® 1947š óuz Rjªâu« »il¤jJ. vÅD« bk¡fhny fšÉ KiwÆÈUªJ Rjªâu«
»il¡fÉšiy. mj‹ fhuzkhfnt moikÆ‹ nkhf« khwÉšiy! ïÅahtJ khWkh?
M« mj‰fhd m¿F¿fŸ njh‹w Mu«ã¤J É£lJ. fšÉ¤ â£l¤âš kh‰w«. Ód
braÈfS¡F¤ jil V‰Wkâ¡F c¤ntf«, ïw¡FkâfS¡F¡ f£L¥ghL v‹w
m¿F¿fŸ e«ã¡ifia¤ jU»‹wJ.
thœf itaf« ! ts®f kUªJ tÂf®fŸ ey‹ !! X§Ff ïªâa âUeh£o‹ òfœ !!!
v‹W« m‹òl‹
- MáÇa®
TAMILNADU CHEMISTS 5 AUGUST SEPTEMBER 2020
 General Secretary’s Desk
30.06.2020 Letter sent to Hon’ble Chief Minister Shri Edapadi K. Palanisamy regarding
the harassments faced by our Chemists by ST Authorities and Policemen
at Tirunelveli on 30.06.2020 during this Corona Pandemic situation.
Requested him to look into the matter and enable chemists to function
without any hurdles.
30.06.2020 Letter by E-mail sent to Office Bearers, AIOCD EC Members (TNCDA),
President / Secretary / Treasurers of Madurai, Ramnad, Dindigul, Theni,
Virudhunagar, Tirunelveli, Thoothukudi and Kanyakumari regarding the
Video Conference Meeting as per agenda to be held on 01.07.2020.
01.07.2020 Letter by mail sent to Office Bearers, AIOCD, EC Members (TNCDA)
President / Secretary / Treasurers of Ariyalur, Perambalur, Pudukottai,
Nagapattinam, Sivagangai, Trichy, Thanjavur and Tiruvarur regarding the
Video Conference Meeting as per agenda to be held on 03.07.2020.
01.07.2020 Letter by email sent to Office Bearers, AIOCD EC Members (TNCDA),
President / Secretary / Treasurer of Dharmapuri - Krishnagiri, Erode, Karur,
Kovai, Namakkal, Nilgris, Salem and Tirupur districts regarding the Video
Conference Meeting as per agenda to be held on 04.07.2020.
06.07.2020 Letter by email sent to Office Bearers, AIOCD EC Members (TNCDA),
President / Secretary / Treasurer of Chennai, Chengalpattu, Cuddalore,
Kanchipuram, Tiruvallur, Thiruvannamalai, Vellore and Vilupuram
Districts regarding the Video Conference Meeting as per agenda to be
held on 07.07.2020.
08.07.2020 Letter by email sent to All EC Members regarding the EC meeting to be
held on 26.07.2020 (Sunday) by Video Conference Call.
16.07.2020 Letter by email sent to All Districts Retailwing Chairmen regarding the
District Level Retailwing Meeting to be held on 19.07.2020 by Video
Conference Call.

TAMILNADU CHEMISTS 6 AUGUST SEPTEMBER 2020

20.07.2020 Letter by email sent to All Districts Wholesale Wing Chairman regarding
the District Level Wholesale Wing Meeting to be held on 23.07.2020 by
Video Conference Call.
28.07.2020 Letter sent to the Chairman, CL Baid Metha College of Pharmacy,
Thoraipakkam, Chennai requesting Pharm D Course admission for Shri
R. Rohit Ashwin one of our member’s son
30.07.2020 Letter by email sent to all district President/Secretary/Treasurers regarding
the decision taken at our EC Meeting held on 26.07.2020 to against a
“Price Fixing Committee” of point associates to ensure uniform price and
supply of Covid-19 Products and also for future situations.
31.07.2020 Letter by email sent to Office bearers AIOCD EC Members (TNCDA) all
Districts President/Secretary/Treasurers and Co-Chairman/Retail Wing of
all Districts regarding the meeting of Retailwing issues to be held on
02.08.2020 by Video Conference Call.
06.08.2020 Letter by email sent to Hon’ble Prime Minister Shri. Narendra Modi
regarding the Tele medicine Practice Guidelines issued by Band of
Governor of Medical Council of India. We had requested him to consider
our suggestions before implementing the same. Copies have been sent to
all concerned Central Government officials.
06.08.2020 Letter by email sent to all Dist President/Secretary requesting them to
send our Memorandum sent to Hon’ble Prime Minister Shri Narendra
Modi in their association letter head.
07.08.2020 Letter sent to the Trustees, Tamilnadu Chemists and Druggists Educational
Trust, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai
requesting the include our President Mr. K. Manoharan and Treasurer Mr.
S. Elangovan as Trustees in the Trust.
- General Secretary

Visit our Website “www.tncda.com”

for updated information

TAMILNADU CHEMISTS 7 AUGUST SEPTEMBER 2020

 bghJ¢brayhs® F¿¥ngL
30.06.2020 ekJ jÄHf Kjšt® âU. vl¥gho nf. gHÅrhÄ mt®fS¡F, 30.06.2020 m‹W
âUbešntÈÆš ekJ r§f kUªJ fil cW¥ãd®fŸ ÛJ tUthŒ¤Jiwí«,
fhtšJiwí« bfhL¤j ï‹dšfŸ g‰¿ F¿¥ã£L jFªj elto¡if vL¡FkhW
Ä‹dŠrš _y« foj« mD¥g¥g£lJ. j‰nghJ cŸs bfhuhdh ghâ¥ãš kUªJ
fil cW¥ãd®fŸ k¡fs¡F nrit brŒ»‹w ÃiyÆš ïªj elto¡fŸ bgÇJ«
ghâ¡»‹wd v‹W Étukhf vL¤Jiu¡f¥g£LŸsJ.
30.06.2020 Ä‹dŠrš _y« khÃy jiyt®fŸ, AIOCD bra‰FG cW¥ãd®fŸ (TNCDA)
k‰W« kJiu, uhkehjòu«, â©L¡fš, njÅ, ÉuJef®, âUbešntÈ, ö¤J¡Fo
k‰W« f‹ahFkÇ kht£l jiyt®/brayhs®/bghUshs® M»nahU¡F 01.07.2020
m‹W eilbgwîŸs Video Conference Call T£l« g‰¿ jftš mD¥g¥g£lJ.
01.07.2020 Ä‹dŠrš _y« khÃy jiyt®fŸ, AIOCD bra‰FG cW¥ãd®fŸ (TNCDA)
k‰W« mÇaÿ®, bgu«gÿ®, òJ¡nfh£il, ehf¥g£od«, átf§if, âU¢á,
jŠrhñ® k‰W« âUth%® kht£l jiyt®/brayhs®/bghUshs® M»nahU¡F
03.07.2020 m‹W eilbgwîŸs Video Conference Call T£l« g‰¿ jftš
mD¥g¥g£lJ.
01.07.2020 Ä‹dŠrš _y« khÃy jiyt®fŸ, AIOCD bra‰FG cW¥ãd®fŸ (TNCDA)
k‰W« jUkòÇ, »UZz»Ç, <nuhL, f%®, nfhit, ehk¡fš, Úy»Ç, nry« k‰W«
âU¥ó® kht£l jiyt®/brayhs®/bghUshs® M»nahU¡F 04.07.2020 m‹W
eilbgwîŸs Video Conference Call T£l« g‰¿ jftš mD¥g¥g£lJ.
06.07.2020 Ä‹dŠrš _y« khÃy jiyt®fŸ, AIOCD bra‰FG cW¥ãd®fŸ (TNCDA)
k‰W« br‹id, br§fšg£L, fhŠáòu«, flÿ®, âUtŸq®, âUt©zhkiy,
ntÿ® k‰W« ÉG¥òu« kht£l jiyt®/brayhs®/bghUshs® M»nahU¡F
07.07.2020 m‹W eilbgwîŸs Video Conference Call T£l« g‰¿ jftš
mD¥g¥g£lJ.
08.07.2020 Ä‹dŠrš _y« mid¤J kht£l bra‰FG cW¥ãd®fS¡F« 26.07.2020 m‹W
Video Conference Call _ykhf ekJ khÃy bra‰Fg T£l« eilbgW« v‹w
jftš mD¥g¥g£lJ.
16.07.2020 Ä‹dŠrš _y« mid¤J kht£l ášyiw kUªJ tÂf mÂ
jiyt®fS¡F 19.07.2020 m‹W khÃy msÉyhd ášyiw kUªJ tÂf
jiyt®fŸ T£l« Video Conference Call _ykhf eilbgW« v‹W
bjÇÉ¡f¥g£lJ.

TAMILNADU CHEMISTS 8 AUGUST SEPTEMBER 2020

20.07.2020 Ä‹dŠrš _y« mid¤J kht£l bkh¤j kUªJ tÂf m jiyt®fS¡F
23.07.2020 m‹W khÃy msÉyhd bkh¤j kUªJ tÂf m jiyt®fŸ T£l«
Video Conference Call _ykhf eilbgW« v‹W bjÇÉ¡f¥g£lJ.
28.07.2020 C.L. bgŒ£ nk¤jh fšÿÇ¡F ekJ r§f cW¥ãd® kfÅ‹ Pharm-D Course-
¡fhd É©z¥g¤ij gÇÓyid brŒí«go nf£L¡bfhŸs¥g£lJ.
30.07.2020 Ä‹dŠrš _y« mid¤J kht£l jiyt®/brayhs®/bghUshs® M»nahU¡F
26.07.2020 m‹W Video Conference Call _ykhf eilbg‰w ekJ khÃy
bra‰FGÉš ‘Price Fixing Committee’ v‹w fÄ£o mik¡f x¥òjš
mË¡f¥g£lJ v‹W Tw¥g£lJ. ïªj fÄ£o _y« j‰nghJ k‰W« tU«
fhy§fËš xU Stockists _ykhf xnu Ãiyahd ÉiyÆš j£L¥ghL ïšyhkY«
Supply brŒa tÊ tF¥ngh« v‹W« Tw¥g£lJ.
31.07.2020 Ä‹dŠrš _y« khÃy jiyt®fŸ, AIOCD bra‰FG (TNCDA) cW¥ãd®fŸ
k‰W« mid¤J kht£l jiyt®/brayhs®/bghUshs® k‰W« Retailwing Co-
Chairman M»nahU¡F 2.8.2020 m‹W eilbgwîŸs ášyiw kUªJ
tÂf®fË‹ Issue g‰¿ Video Conference Call T£l« g‰¿ jftš mD¥g¥g£lJ.
06.08.2020 Ä‹dŠrš _y« ekJ ghuj ãujk® âU. enuªâu nkho mt®fS¡F Medical
Council of India btËÆ£LŸs Telemedicine Practice Guidelines g‰¿ mâYŸs
FiwfŸ g‰¿ ÉÇthf vL¤Jiu¡f¥g£lJ. ekJ Suggestionsfisí« fU¤âš
bfh©L Koî vL¡FkhW nf£L¡ bfhŸs¥g£lJ. ïªj foj¤âš efš ïªj
Jiwia rh®ªj K¡»a cW¥ãd®fS¡F« mD¥g¥g£lJ.
06.08.2020 Ä‹dŠrš _y« mid¤J kht£l jiyt®/brayhs®/bghUshs® M»nahU¡F
TNCDA _y« ekJ ghuj ãujk® âU. enuªâu nkho mt®fS¡F Telemedicine
Practice Guideleines g‰¿ mD¥ãa foj« nghš mid¤J kht£l§fS«
j§fSila kht£l r§f¤â‹ Letter Head-š il¥ brŒJ Ä‹dŠrš _ykhf
midtU¡F« mD¥ò«go nf£L¡bfhŸs¥g£lJ.
07.08.2020 Trustees, Tamilnadu Chemists and Druggists Educational Trust, C.L. Baid Metha
College, Jiu¥h¡f¤â‰F ekJ khÃy jiyt® âU. K. kndhfu‹ mt®fŸ k‰W«
bghUshs® âU. S. ïs§nfht‹ M»a ïUtiuí« nk‰go Trust-š Trustees
Mf ÃaÄ¡F«go foj« mD¥g¥g£lJ.
- bghJ¢brayhs®

TAMILNADU CHEMISTS 9 AUGUST SEPTEMBER 2020

 kht£l brŒâfŸ
br§fšg£L kht£l«

br§fšg£L kht£l« X£nlÇ kÂth¡f« jhY¡fh fÞöÇ bko¡fšÞ cÇikahs®

mt®fŸ rÛg¤âš uîofshš Äu£l¥g£lh®. jÄœehL tÂf® r§f nguik¥ò jiyt®
âU. A. É¡»ukuh#h neÇš br‹W mtU¡F ijÇaK«, MWjY« bjÇɤjh®. mt®fSl‹
br§fšg£L kht£l kUªJ tÂf®fŸ r§f îth»fŸ clÅUªjd®.
âUbešntÈ kht£l«

11.08.2020 ï‹W fhiy jiyt® N. fU¥igah mt®fŸ, brayhs® P.Þog‹ mt®fŸ,

bkh¤j kUªJ tÂf jiyt® âU. mwthË M»nah® Deputy Commissioner of Police
âU. rutz‹ mt®fis kÇahij ÃĤjkhf rªâ¤J %ghŒ 10,000/- kâ¥òŸs khÞ¡ k‰W«
sanitizer bfhL¤jd®. nkY« mt®fËl« 24 k neuK« kUªJ fil âwªJ it¥gj‰F
Mtd brŒíkhW nfhÇ¡if it¤jd®.
TAMILNADU CHEMISTS 10 AUGUST SEPTEMBER 2020
 âUbešntÈ kht£l kUªJ tÂf®fŸ r§f¤â‹ bra‰FG T£l« r§f f£ol¤âš
22.07.2020 m‹W eilbg‰wJ. ï¡T£l¤âš 15 cW¥ãd®fŸ fyªJ bfh©ld®. fyªJ
bfhŸs ïayhjt®fŸ bjhiyngá _y« bjhl®ò bfh©L fyªJ bfh©ld®. òâajhf
bj‹fhá kht£l« ãǪJ brštjhš bj‹fháÆš òâa kUªJ tÂf®fŸ r§f« Mu«ã¡f
ïU¥gjhš ekJ kht£l¤â‰F brayhs® gjÉ¡F brayhs® bjǪJ vL¡f ï¡T£l¤âš
Koî brŒa¥g£lJ. r§f¤â‹ _¤j cW¥ãd® âU. P. ÞOg‹ mt®fis bra‰FG
cW¥ãd®fŸ K‹bkhÊa âU. P. ÞOg‹ mt®fŸ brayhsuhf bghW¥ò V‰W¡ bfh©lh®fŸ.
fhÈahf cŸs Retailwing-Chairman gjÉ¡F vutho, e«ng bko¡fšÞ âU. A. khÇa¥g‹
mt®fŸ nj®î brŒa¥g£lh®. ïªâa‹ t§», âUbešntÈ #§õÅš r§f¤â‹ bgaÇYŸs
t§» fz¡if òâa îth»fŸ ît»¡f T£l¤âš mDkâ¡f¥g£lJ. Kjyik¢r®
Ãthuz Ãâ¡fhf jÄœehL r§f¤â‹ _y« %. 1,00,000/- bfhL¤jJ gâî brŒa¥g£lJ.
brayhs® âU. P. ÞOg‹ mt®fŸ e‹¿ Tw T£l« Ãiwî bg‰wJ.
bj‹fhá kht£l«

24.07.2020 m‹W thbdhÈ fh£á _ykhf khÃy jiyt®, khÃy brayhs®, khÃy
bghUshs®, mik¥ò brayhs® k‰W« khÃy îth»fŸ K‹ÅiyÆš giHa F‰why« ghÇ
kî©£ fh®lÅš bj‹fhá jhYfh K‹ndhofŸ fyªJ bfh©L òâa bj‹fhá kht£l«
kUªJ tÂf®fŸ r§f« Jt¡f ÉHh jÄœ¤jhŒ thœ¤Jl‹ F¤J És¡F V‰w¥g£L
tunt‰òiuíl‹ Jt§f¥g£lJ. jiytuhf âU. V.M. fhj® ikÔ‹ mt®fS«, brayhsuhf
âU. K. rhFš fÛJ mt®fS«, bghUshsuhf âU. K. fdfuh{ Fkh® mt®fS«, òutyuhf
âU. C. uFehj‹ mt®fS«, bkh¤j kUªJ tÂf®fŸ jiytuhf âU. M. m¥Jš ké¤

TAMILNADU CHEMISTS 11 AUGUST SEPTEMBER 2020

mt®fS«, ášyiu kUªJ tÂf®fŸ r§f jiytuhf âU. S. á‹d fU¥igah mt®fS«,
Jiz¤jiytuhf âU. K.M. fhªâkâ ehj‹ mt®fS«, ïiz¢brayhsuhf âU. S.
KA«kJ ôR¥ m‹rhÇ mt®fS« khÃy kht£l îth»fŸ K‹ÅiyÆš gjÉ V‰wd®.
khÃy îth»fŸ thœ¤Jiu tH§»d®. kht£l brayhs® âU.K. rhFš fÛJ mt®fŸ
e‹¿ ciu Tw, eh£L¥g© ïir¡f¥g£L T£l« ïÅnj Ãiwî‰wJ.
áj«gu« kht£l«

áj«gu« m©zhkiy ef® ng%uh£áÆš gÂòÇí« öŒik gÂahs®fŸ

m©zhkiy gšfiy¡fHf bgh¿Æaš fšÿÇÆš mik¡f¥g£LŸs bfhnuhdh Ợir
th®oš ntiy gh®¤J tU»wh®fŸ. ït®fS¡F k¤âa, khÃy muRfË‹ m¿îW¤jÈ‹go
flÿ® kht£l kUªJ tÂf®fŸ rh®ãš bfhnuhdh jL¥ò elto¡ifahf (M®rÅ¡ Mšg«
30) nehŒ v⮥ò r¤J kh¤âiu tH§F« Ãfœ¢á ng%uh£á mYtyf tshf¤âš elªjJ.
ïj‰F ng%uh£á braš mYty® âU. bt§f£ukz‹ mt®fŸ jiyik jh§»dh®. XÄnah
kU¤Jt® âU. guÂju‹ mt®fŸ, jÄœehL kUªjhSd® r§f brayhs® âU.
J.bt§flRªju« M»nah® fyªJ bfh©L öŒik gÂahs®fS¡F nehŒ v⮥ò r¤J
kh¤âiufŸ tH§»d®. ïâš m©zhkiyef® kUªJ tÂf® r§f bghW¥ghs® âU. $j®
mt®fŸ cŸgl gy® fyªJ bfh©ld®.
âU¥ó® kht£l«
âU¥ó® kht£l kUªJ tÂf®fŸ r§f¤â‹ áw¥ò bra‰FG T£l« 14.09.2020
â§f£»Hik m‹W kâa« 3.00 k msÉš P.N. nuhL, á£o bko¡fšÞ tshf¤âš
eilbg‰wJ. ïªj áw¥ò bra‰FG T£l¤âš kht£l jiytuhf âU. A. gHÅ¢rhÄ mt®fS«,
brayhsuhf âU. P. yºkz‹ mt®fS«, bghUshsuhf âU. N. Ff‹ mt®fS« mid¤J
bra‰FG cW¥ãd®fshš Vfkdjhf, kht£l¤â‹ òâa îth»fshf nj®ªbjL¡f¥g£ld®. òâa
îth»fŸ midtU¡F« jÄœehL kUªJ tÂf® r§f¤â‹ rh®ghf thœ¤J¡fŸ
bjÇÉ¡f¥g£lJ.
TAMILNADU CHEMISTS 12 AUGUST SEPTEMBER 2020
ESTD.] [1975

AIOCD
ALL INDIA ORGANISATION OF CHEMISTS & DRUGGISTS ®
201, Safalya Bldg., 2nd Floor, Opp. Jaigopal Industrial Estate, Baburao Parulekar Marg, Dadar (W), Mumbai 400 028.
Tel.: 2430 6889 / 2430 6874 / 6145 2929 l Fax: 2430 6973 / 6145 2925 l Visit us on : www.aiocd.net
President : Hon. Gen. Secretary :
J.S. SHINDE RAJIV SINGHAL
Email: aiocd@vsnl.net M/s. Shree Radhey Trade Logistics,
jagannath.shinde@aiocd.com Prabhu Kripa 120, S.R. Compound,
Lasudia, Indore - 452 010, M.P.
August 3, 2020 Tel. : 0731 - 4002350 Mob.: 9425056394
E-mail: gsrajiv.singhal@aiocd.com
Ref: APH/AIOCD/638/2020
To,
All Distributors/Marketing/Finance Head of Pharma companies
Sub: Settlement of leakage/Breakage/Expiry without any Deductions
We are thankful to all those companies, already issued letters, providing 120 extra days, in addition to 180
days for the settlement of L/B/E, responding to our appeal with reference to our communication Ref :APH/
AIOCD/578/2020 dated 2nd April 2020 and Ref: APH/AIOCD/607/2020 dated 8th May 2020, regarding the
settlement of L/B/E without any deductions to your stockists.
Although all Pharma Companies have instructed to their CFA/Deport/Distribution that L/B/E shall be settled
without any deductions & Credit Note shall be given against receipt of L/B/E goods considering 120 days
extra; over and above normal settlement days of 180 days.
AIOCD had also appealed to consider relaxation in settlement of L/B/E for those stockist located in
containment areas of various states JUTs and still facing challenges of transportation. Principally it’s requested
to all Pharma companies to settle claims without deductions on any reason till normalcy returns.
If there is any ambiguity please instruct to your CFA/Deport /Distributor immediately, so that our members
both Retailers and wholesalers regarding settlement of L/B/E are not put in any loss due to the zero value
credit note because of Covid Period.
Hope all of you will co-operate in this crucial moment.
Thanking you
Yours faithfully,
For The All India Organisation of Chemists & Druggists

(J.S. Shinde) (Rajiv Singhal)

President Hon Gen Secretary
CC : All States President /Secretaries of AIOCD

Regd. Office : AIOCD, C/o. B.C.D.A., 10, Bonfield Lane, 1st Floor, Kolkata - 700 001.

TAMILNADU CHEMISTS 13 AUGUST SEPTEMBER 2020

 File No. 4-01/2013-DC (Misc. 13-PSC) (Pt. III)
Govt. of India
Directorate General of Health Services
Central Drugs Standard Control Organization
(FDC Division)
To, Dated: 03.08.2020
All State/UT Drugs Controllers
Subject: Procedure to be followed for subsequent applicant in respect of FOCs relating to Vitamins,
Minerals and Micronutrients declared as rational by Prof. Kokate Committee and approved by
DCG(I) - regarding.
Sir,
Please refer to this Directorate’s letter of even numbered dated 12.12.2018 and 08.01.2020 where by all the
State Licensing Authorities were requested to ask the concerned manufactures to follow the procedure as mentioned
in the said letter for obtaining manufacturing licenses directly from SLAs. The list of such rational FOCs containing
1681 FOCs and 450 FDCs were already forwarded with the said letter to the State Licensing Authorities.
In continuation to the said letter, it may be noted that apart from these 1681 FOCs and 450 FOCs, further there are
now more 471 FOCs (attached as Annexure-A) relating to Vitamins, Minerals and Micronutrients, etc., which have
been declared as rational by Prof. Kokate Committee and report of the committee has been accepted by the
Ministry Accordingly with the approval of the Ministry of Health and family Welfare, it has been now decided to
follow the following pathway for grant of product licenses by SLAs for these FOCs:-
1. Applicants shall submit the requisite fees preferably through Bharatkosh for each FOC to COSCO as specified
under Drugs and Cosmetic Act, 1940 and existing Rules thereunder.
2. The applicant shall submit application to the concerned SLA as per the provisions of Drugs and Cosmetics
Rules 1945 for grant of product manufacturing license giving the details of FOC, S. No. of the FOC in the list,
stability studies data (6 months accelerated), Test Specification of the FOC alongwith Method of Analysis as
well as label and other documents as required for grant of product license under Drugs and Cosmetics Rules.
3. State Licensing Authority shall grant the product license of such FOCs without seeking NOC from OCG (I), if
other conditions of license under the Drugs and Cosmetics Rules, which need to be verified by SLA, are
found to have been fulfilled. The SLAs shall verify the quality of such FOCs of each applicant/manufacturer,
before grant of License.
4. Every manufacturer permitted to manufacture these FDCs shall submit the periodic safety update reports
(PSURs) as per New Drugs and Clinical Trial Rules-2019 to the central Licensing Authority as defined in Rule
‘3’ i.e. DCG(I). Failure to submit the PSURs shall be considered as contravention of these Rules.
In view of above, you are requested to ask the concerned stakeholders to follow the above procedure for obtaining
the manufacturing license w.r.t. FDCs declared as rational by Prof. Kokate Committee. You are therefore requested
to ensure that no product license is granted in respect of the FDCs which are not mentioned in the attached list.
Yours faithfully,
(Sd/-)
(Dr. V. G. Somani)
Drugs Controller General (India)
Copy to:-
1. PPS to Secretary/AS(F&D)/JS(R), Ministry of Health and Family Welfare, Nirman Bhawan, New Delhi.
2. All Zonal/Sub Zonal offices of CDSCO
3. Indian Drug/Pharmaceuticals Association Forum
4. Website of CDSCO

ïj‹ KG ÉtuK« ekJ TNCDA Website š gâî brŒa¥g£LŸsJ.

TAMILNADU CHEMISTS 14 AUGUST SEPTEMBER 2020

 F. No. 04-146/2007-DC (Part-I)
Government of India
Directorate General of Health Services
Central Drugs Standard Control Organization
(FDC Division)
FDA Bhawan, Kotla Road,
New Delhi
Dated: 8/9/2020
To
All State/UT Drugs Controller
Subject:- Procedure to be followed for regularisation of FDCs declared as rational in respect
to 294 FDCs by the DTAB which were licensed to manufacture and market by
State Licensing Authority (SLA) without prior approval from DCG(I)-regarding.
Sir,
This is in continuation to this Directorate letter of even number dated 27.02.2019 whereby a detailed
pathway was issued for obtaining permission from this Directorate in respect of 83 FOGs declared
as rational (copy enclosed). Subsequently, the date for submission of such applications was also
extended vide this office letter dated 19.08.2019. However, there have been concerns that there is
no mention of strength and dosage forms in the said list.
It is pertinent to mention here that as regard to strength and dosage forms of such FOGs mentioned
in 83 rational FOGs list, it is to clarify that if the manufacturer submits copy of product license
issued by SLA to any firm indicating that the product in specific dosage form and strength was
licensed prior to 28.11 .2007, the same will be considered for issuance of permission by this office
in accordance with the defined pathway.
As per the report of DTAB dated 29.07.2020, there are 3 more FOGs which have been considered
as rational under 294 FOGs category. The pathway for obtaining permission w.r.t. these 3 FOGs
will also remain same as already defined under this office letter no. 04-146/2007-DG (Part-I) dated
27.02.2019. The details of these FOGs are as under:-
Sr. No. Name of the FDC
1 Atenolol + Losartan + Hydrochlorothiazide
2 Duloxetine + Mecobalamin
3 Mecobalamin + Vit. 86 + Folic Acid
Further” it has been observed that only a few applicants who are already having manufacturing
licenses for such FOGs issued by SLA have applied for obtaining approval from this office. Now, it
has been decided that manufacturers/stakeholders who are already holding license for these FOGs
from SLA may submit their applications latest by 31.03.2021.
In view of above, you are requested to ask the manufacturers who are already holding licenses of
these (83+03) FDCs under your jurisdiction to submit the applications to this Directorate as per
defined pathway as no further extension will be considered in such cases.
Copy to:- Yours faithfully,
1. JS(R), Ministry of Health and family Welfare, (S/d)
Nirman Bhawan, New Delhi (Dr. V. G. Somani)
2. All State/UT Drugs Controllers Drugs Controller General (India)
3. CDSCO Zonal and Sub-Zonal offices
4. Indian Drug/Pharmaceuticals Associations
5. Website of CDSCO

TAMILNADU CHEMISTS 15 AUGUST SEPTEMBER 2020

 F. No.04-146/2007 -DC (Part-I.)
Government of India
Directorate General of Health Services
Central Drugs Standard Control Organization
(Fixed Dose Combination Division)

FDA Bhawan, Kotla Road,

New Delhi
Dated: 27 FEB 2019
To
All State/UT Drugs Controller
Subject: Procedure to be followed for regularisation of FIDCs declared as rational in respect to
294 FDCs by the DTAB which were licensed to manufacture and market by State
Licensing Authority without prior approval from DCG(I)- regarding
Sir,
The office of Drugs Controller General (India) received complaints from Consumer Associations in
year 2007 regarding rationality of certain Fixed Dose Combinations (FDC) marketed in the country.
As a part of follow up action of complaints, the office of DCG(I) prepared a list of 294 FDCs and
directions were issued to all States/UTs Drugs Controllers to withdraw these 294 FDCs which were
licensed without approval of DCG(I). The manufacturers association got however stay from the
Hon’ble High Court of Madras in respect of directions issued in the matter.
The matter was then placed in DTAB in the 56th meeting dated 16.01.2008. A Sub Committee was
constituted by DTAB to examine these FDCs. Accordingly the Subcommittee examined these
FDCs and submitted its report to the DTAB. DTAB in its meeting held on 16.02.2015 agreed with
the recommendations of Sub-Committee of DTAB. All Court cases pending in Hon’ble Madras
High Court were transferred to Hon’ble Supreme Court. In this regard Hon’ble Supreme Court
accepted the report of DTAB as per court order dated 15.12.2017.
As per the report of DTAB, there are 83 FDCs considered as rational. The list of these 83 FDCs ,is
already available in CDSCO website with the following link:
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO. WEB/elements/
download_file division.jsp?num_id=MTUxNQ==
In order to regularise these 83 FDCs, which were licensed to manufacture and market by State
Licensing Authority without prior approval from DCG (I), following procedure is required to be
followed :
a. The applicant shall submit Form 44 mentioning dosage form and strength (duly filled, signed
and stamped) alongwith treasury challan of INR 15,000 for each FDC.

TAMILNADU CHEMISTS 16 AUGUST SEPTEMBER 2020

b. Name and Composition of FDC
c. Copy of Product Permission issued by SLA to any firm prior to 28.11 .2007 as documentary
evidence.
d. Copy of manufacturing license in Form 25/28 and Form 29 for manufacturers who are not
holding product permission from SLA and want to apply for these FDCs
e. S.No. of FDC as per the list available on website,
f. Stability studies data (06 months accelerated data of 03 batches) and
g. Test specifications of the FDC along with Method of Analysis
All the manufacturers who are already holding licenses from State Licensing
Authorities for such FDCs and did not obtain NOC from DCG (II) are required to submit their
applications to this Directorate at the earliest but hot later than 4 months, failing which their
applications will not be considered and their licenses will be considered as without legal validity.
In view of above, you are requested to direct all concerned stakeholders to follow above procedure
for clearance of the cases. You are also requested to ensure that no product licensed in respect of
these 83 FDCs are issued henceforth without the approval of DCG (I) in favour of the applicant.
Yours Faithfully
(Sd/-)
(Dr. S. Swara Reddy)
Drugs Controller General (India)
Copy for information and necessary action to:-
1. PS to JS(R) , Ministry of Health and Family Welfare, Nirman Bhawan, New Delhi.
2. CDSCO Zonal and Sub-Zonal offices.
3. Indian Drug/Pharmaceuticals Association Forum
4. Website of CDSCO.

thœ¤J»nwh«
âUtŸq® kht£l r§f cW¥ãdU«, âU¤j efu«, V gh®kh cÇikahsUkhd bršt‹
J.R. tujuh#‹ M.B.A. mt®fS¡F«, bršÉ T. ãÇah B.Sc., B.Ed. mt®fS¡F« 23.08.2020 m‹W
K.G. f©oif Shanjamma Konai Temple tshf¤âš âUkz« áw¥ghf eil¥bg‰wJ.
âUtŸq® kht£l r§f cw¥ãdU«, K.B. f©oif »uhk« $ rhŒ rªâuh bko¡fšÞ
cÇikahs® âUkâ. C. ckhr§fÇ - C. ghòuhé j«gâaÇ‹ kfŸ bršÉ Rishmitha mt®fS¡F«,
bršt‹ É¡u« rhŒ mt®fS¡F« 28.08.2020 m‹W K.G. f©oif átr¡â á¤njÞtuh Mya
tshf¤âš âUkz« áw¥ghf eilbg‰wJ.
ïÅa e‹dhËš ïšthœ¡if bjhl§F« ï¤j«gâa®fS¡F«, ÉHh fhQ« cW¥ãd®fS¡F«
khÃy r§f¤â‹ ešyhá k‰W« kd§fŪj ešthœ¤J¡fŸ.

TAMILNADU CHEMISTS 17 AUGUST SEPTEMBER 2020

To: Dated 6th August 2020
Hon. Shri Narendera Modi Ji,
Prime Minister of India,
Prime Minister’s Office,
South Block, Raisina Hill,
New Delhi - 110011,
connect@mygov.nic.in,
narendramodi1234@gmail.com
Subject: Tele Medicine Practice Guidelines issued by Board of Governor in
supersession of Medical Council of India
Respected Sir,
We are writing in relation to the Telemedicine Practice Guidelines (“Telemedicine Guidelines”),
notified- by Board of Governors in supersession of Medical Council of India by amending the
Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulation, 2002.
1. We understand that Telemedicine Consultation has the apparent objective to ease access to
healthcare for patients and we do encourage adopting technology in the health care services.
However, for telemedicine consultation be effective and in public interest it should be done in
accordance with the provisions of Drugs and Cosmetics Act, 1940 Pharmacy Act, 1948 and
rules and regulations framed there under. We are writing to point out glaring irregularities in
the Telemedicine Guidelines which, if not corrected immediately, would lead to misuse of
telemedicine, and put public health to a great risk.
2. Background of Our Association . Tamilnadu Chemists & Druggists Association is the affiliated
Association with AIOCD. Our main motive and objective is to provide a platform for interaction
with Food Drug Administration and implement good trading process by complying with D&C
Act and Rules. Our Association playa proactive role in containing the menace of spurious
drugs and is a watchdog to prevent the entry of doubtful medicines in market. All the Chemists
and Pharmacists in State of Tamil Nadu are members of our association. The PMO prior to
announcing the nationwide lockdown on account of COVID-19 had consulted our parent
Association AIOCD so that the supply of medicines is not interrupted.

TAMILNADU CHEMISTS 18 AUGUST SEPTEMBER 2020

3. The Mashlekar Committee set up by Govt of India to examine the drug regulatory issues in its
report dated November 2003 had consulted AIOCD and had opined that trade associations
like AIOCD play an important role in preventing the sale of spurious drugs in market.
4. Scanned prescription cannot be stamped at the time of dispensing: As per the Telemedicine
Guidelines, doctors can in professional discretion prescribe medicines via tele consultation
by providing ‘photo, scan, digital copy of a signed prescription or e-Prescription to the patient
via email or any messaging platform ‘or by ‘transmitting the prescription directly to a
pharmacy. Needless to say, prescription drugs can be harmful if taken without medical advice
or in wrong dosage.
Therefore, issuing the prescription in tele medicine consultation and the dispensing of such
prescription by pharmacist should entail same professional accountability as in traditional in-
person consultation. However, as explained here in below, the Telemedicine Guidelines insofar as
it seeks to validate photo, scanned, digital copy of a prescription for buying prescription drugs is
against the provisions of Drugs and Cosmetics Act, 1940, the Pharmacy Act, 1948 and Rules
framed there under and warrants an urgent rethinking since it has the potential of affecting
public health on a large scale.
5. It is well known that prescription drugs are dangerous if consumed except in accordance with
medical advice. Many prescription drugs are habit forming, addictive and can be dangerous if
not consumed properly. It is a matter of common knowledge that in India there are numerous
cases of drug abuse, drug misuse and self medication which can give rise to dangers associated
with antibiotic resistance. In this context Rule 65 (11)(c) of the Drugs and Cosmetics Rules,
1945 is important as it provides that at the time of dispensing prescription medicines, the
pharmacist should stamp the medicines as dispensed on prescription. This is so that no other
pharmacist would second dispense the same medicines. The objective being that one
prescription is not dispensed multiple times. The Rule 65( II) is extracted hereunder for
reference:
Rule 65(11):
The person dispensing a prescription containing a drug specified in Schedule H and Schedule
H1 and Schedule X shall comply with the following requirements in addition to other
requirement of these rules.
(a) the prescription must not be dispensed more than once unless the prescriber has stated
thereon that it may be dispensed more than once;
(b) if the prescription contains a direction that it may be dispensed a stated number of times
or at stated intenals it must not be dispensed otherwise than in accordance with the directions;
(c) at the time of dispensing there must be noted on the prescription above the signature of
the prescriber the name and address of the seller and the date on which the prescription is
dispensed.

TAMILNADU CHEMISTS 19 AUGUST SEPTEMBER 2020

 The Telemedicine Guidelines allow the doctors to issue prescription by sending photograph
of scanned copy of the prescription to patients. The scrumed copy of prescription or photograph
of prescriptions not valid under applicable laws since it cannot be stamped to prevent multiple
dispensation. Such scenario gives rise to many risks, for example:
i. Once prescription is presented in pharmacy, the law requires stamping of prescription by
the pharmacist to avoid multiple dispensing. However, scalmed prescription can lead to
multiple dispensing as it can be used multiple times since there is no mechanism to stamp
such a prescription. The patients can print a fresh copy of the scanned prescription and
use it in another pharmacy.
ii. Multiple dispensing of prescription can also lead to increase in self-medication which
can give rise to dangers associated with it such as generating antibiotic resistance. It is
well know that Antimicrobial resistance (AMR) has emerged as a major threat to public
health. AMR develops when microbes develop mechanisms to evade the action of
antimicrobials. The factors that contribute to AMR include irrational and overuse of
antibiotics. The high burden of AMR in India is driven by multiple factors including over
prescription of antibiotics. Antibiotic over-prescription is driven by a poor understanding
of its dangers and contribution to AMR on the part of the provider as well as patients who
lack knowledge regarding appropriate antibiotic use. It is reported that India carries one
of the largest burdens of drug-resistant pathogens worldwide. In fact NDM-l was reported
in 2008 and the world ascribed it to New Delhi, the capital of India. India is one of the
largest consumers of antibiotics worldwide. For instance, the entire world is blaming
the China for spread of COVID-19 for the due to the inaction of Chinese Administration,
though the COVlD-19 is a virus and not AMR bacteria. The miss utilisation of antibiotic
can result in occurrence of a resilient bacteria with can spread to the world at large.
An outbreak of a new AMR bacteria / superbug will not only cause grave health loss
and economic loss to the country but it can also bring disrepute to the country for not
taking timely and remedial steps.
iii. Anti-depressant drug addiction, dependence on sleeping pills, habit forming prescription
medicines are well known phenomena in India. Multiple dispensing and over dosage of
such medicines can cause impairment of mental faculties and can be fatal.
6. Our Suggestion: To obviate this risk we suggest that the Central Government should establish
a national portal on which the doctors can email prescription and the patients or the pharmacist
can access the prescription by using a unique OTP. The Pharmacist can, after dispensing the
prescription, either deface it or specify the quantity of medicine dispensed on the national
portal itself so that once the medicines are dispensed the prescription cannot be reused. Until
this portal is setup the doctors should not be allowed to issue scanned prescriptions in
telemedicine consultation.
7. Classification of medicines in List O. List A and List B: The telemedicine guide lines classify
medicines into 4 new categories namely List 0, List A and List B, whereas, the Drugs and

TAMILNADU CHEMISTS 20 AUGUST SEPTEMBER 2020

 Cosmetics Act, 1940 which medical practitioners and chemists are accustomed with has a
different list namely Schedule H, Schedule H1 and Schedule X. We fail to understand the
logic in having two separate lists and how can guidelines supersede the Drugs and Cosmetics
Act, 1940 to make a new lis!. The medical practitioners and chemists are used to following
the list under Drugs and Cosmetics Act, 1940 and the new classification is likely to cause
confusion that can lead to wrongful prescribing or wrongful dispensation.
8. Our suggestion: We suggest that telemedicine guidelines should adopt the Schedule provided
in Drugs and Cosmetics Act, 1940 for classifying the medicines into different categories
instead of making a new list. And the List 0, List A and List B in the Telemedicine Guidelines
should be done away with.
9. Location of the consulting doctor : Whereas in physical consultation the patients usually
consult doctors in the same city or town, however, the Telemedicine Guidelines allow medical
practitioners to provide telemedicine consultation from any part of the country. As a result, it
is possible that a doctor who practices in Chennai provides telemedicine consultation to patients
from Delhi. It appears that while framing guidelines the board did not consider that in India
every region/State has peculiar and seasonal health problems due to difference is topography,
geography, and climate. A medical practitioner practicing in the same region has better
understanding of recent outbreaks or common symptoms in the local population and he can
give a better advice. For example, each year Delhi has an outbreak of Dengue post monsoon.
The Government of Delhi every time issues an advisory in public interest that during this time
the use of drugs like aspirin and Ibuprofen should be restricted and to avoid use of antibiotics
because in initial days the symptoms of dengue are misleading and doctors can prescribe
wrong medication to patients. Only a Delhi based doctor would know this and a doctor who is
not aware of the current situation in Delhi may prescribe the wrong medication in view of the
misleading symptoms of Dengue.
10. Our suggestion: We suggest that doctors should be allowed to do tele consultation only in the
same city of town where they are practicing and in case a patient wants to consult a specialist
doctor in another city or town, the same should be permitted through a three way consultation
between patient, local medical practitioner and the specialist.
11. Unethical prescribing and solicitation of patients: It is already a matter of concern that doctors
receive compensation or incentives from pharmaceutical companies to prescribe medicines.
This has become a bigger problem with the advent of E pharmacies which are providing
telemedicine consultation. As it is, E pharmacies are operating illegally in India and in contempt
of orders dated 12.12.2018, 20.12.2018, 11.01.2019 and 06.02.2019 passed by the Hon’ble
High Court of Delhi in WP (C) No. 11711/2018. To add to the problem, if a patient using e-
pharmacy website or mobile application does not have prescription for the medicines, the
epharmacy website or mobile application connects the patient to an affiliated doctor for
consultation.

TAMILNADU CHEMISTS 21 AUGUST SEPTEMBER 2020

These doctors are on the rolls of e-pharmacies. We have seen that these doctors do not undertake
proper consultation and prescribe medicine for the asking to suit the business interest of e-
pharmacies. Such doctors are affiliated to E pharmacies to facilitate the selling medicines. It is
professionally unethical if telemedicine consultation is misused by E pharmacies in this manner
Our Suggestions : The E pharmacies or its affiliates should not be allowed to provide te1e-medicine
consultation, directly or indirectly as it amounts to solicitation of patients by the Doctors and
giving incentives to the Doctors to prescribe medicines.
We hope and sincerely request that these recommendations are considered, and prompt action is
taking by the concerned authorities to safeguard the interest of nation and public health.
Assuring of best services always by from all of our members.
Regards,
For Tamilnadu Chemists & Druggists Association

K. Manoharan K.K. Selvan

President Hon Gen. Secretary
CC:
1. Dr Harsh Vardhan, Minister, Ministry of Health & Family Welfare, New Delhi.
2. Ms Preeti Sudan, Secretary, Ministry of Health and Family Welfare, New Delhi.
3. Shri Amitabh Kant, CEO, Niti Aayog, New Delhi.
4. Dr Vinod Kumar Paul, Member, Niti Aayog, & Chairman, Medical Council of India, New
Delhi.
5. Dr Rakesh Kumar Vats, Secretary General. Medical Council of India,
6. Dr (Mrs) Rcena Nayyar, Additional Secretary, Medical Council of India,
7. Shri Rajesh Bhushan, OSD, Ministry of Health & Family Welfare
8. Shri Arun Singhal, Special Secretary, Ministry of Health & Family Welfare,
9. Shri Mandeep Kumar Bhandari, Joint Secretary, Ministry of Health and Family Welfare, New
Delhi .
10. Dr V G Somani, DCGI, Directorate General of Health Services, Government of India FDA
Bhavan,
11. Dr Rajiv Kumar, Vice Chairman, Niti Aayog., New Delhi.
12. Prof Ramesh Chand, Member, Niti Aayog, New Delhi
13. Dr V K Saraswal, Member. Niti Aayog, New Delhi.
14. President / Secretary, AIOCD

TAMILNADU CHEMISTS 22 AUGUST SEPTEMBER 2020

 bkh¤j kUªjfK« x‹W nr®ªJ ghL« ghlš ïJ
nk¤jh fšÿÇia Û£blL¤j kh¡fnk....
nry ‘kh’ efu¤â‹ á‹dtnu.... k‹dtnu....
kUªâaš tÂf¤âš rhjid¥gil¤j brštnk....
v§fŸ Ãiy¥gh£oš ca®tila brŒjtnu....
150 nfho brh¤J¡fis cÆ®bgw brŒjtnu....
muáaš gy« bfh©L Raey« milahjtnu....
bfhnuhdhit f©L fy§fhjtnu....
bfhnuhdhit f© fy§f it¤jtnu....
f©Q¡F bjÇahj bfhnuhdhitna.... j§fŸ....
fhyneu« gh®¡fhkš ršyilahš rȤjtnu....
v§fS¡F »il¤j bgh‰fhy ‘kh’ kUªnj
É©ÂY« k©ÂY« »il¡fhj brštnk....
v¤jid T£l« ngh£lhY« ngá Koî bgwhj kfh..ghujnk.
nghÞ£ mo¡fhkš rhjid¥ gil¤j bgh‹kd¢ br«kny...
òGâia »s¥ãdhY« f©zho nghlhj fhtnu....
njh‰wtD¡F« bt‹wtD¡F« tuyhW c©L.
ïil¥g£ltD¡nfh “énuh” tuyhW c©L
å«ò¡F kh®uil¤J beŠRtÈ tUtJ©L
fhÇŒjâ‰F kh®òil¤J fhy¤ij bt‹wJ©L
gy ehŸ T£l¤âš neu¤ij nk¤jh fšÿÇ nkŒªjJ©L.
á‹d fil¡fhuD« fhyiu ö¡»Él it¤jtnu....
bgÇa fil¡fhuD« rÇif ngh£l nt£oia f£l it¤jtnu.....
N¥g® fil¡fhuD« bt‰¿iy gh¡F R©zh«ò nghlit¤jtnu....
khÃy¤â‹ K«_®¤âfns KftÇia jªjt®fns....
e« kUªjf¤â‹ cÇikbfho gw¡»wJ nkny t©zkakhf....
fh©ngh® f©fS¡F fhÉa« ngR»wJ T£l« kakhf....
ehisa e« jÄHf¤ij MsnghF« e« ïd k¡fŸ kakhf....
xUKf« gh®¤jtD« gyKf« gh®¡f it¤jtnu....
f©Q¡F bjÇahj RHY« NwhtË fh‰nw....
gšyh¡F ö¡fhkš ò‹dif òÇahkš ïUªj òânu....
bgh¡»õ« fh¤j nry¤â‹ fU¥ò á§fnk....
v§fŸ kUªjf bjhÊY¡F vGj¥g£l KftÇna....
ï‹bdhU rhjid gil¡f ï‹bdhU kÅj‹ ãw¥ghdh....!
K¥ãw¥ãš eh§fŸ kwªjhY« c§fis..... v‹Wnk.....
v§fŸ bjh¥òŸbfho cwî j§fis kw¡fhnj....! kw¡fhnj....!
thœf c‹ brašghL btšfnt c§fŸ Kfhªâu«......
e‹¿íl‹ N.K. fâ®ntš, jiyt®
flÿ® kht£l kUªJ tÂf®fŸ r§f«, ÉUjh¢ry«

TAMILNADU CHEMISTS 23 AUGUST SEPTEMBER 2020

 NEW PRODUCTS PRICE LIST (Form V)
P.T.S. P.T.R.
Product Pack Rate Margin Rate Margin M.R.P.
% %
ABBOTT INDIA LIMITED.,
FAPVIR 200 MG TAB 10s 321.43 10 357.14 20 500.00
favipiravir 200mg

AJANTA PHARMA LIMITED

HYANE EYE DROPS 5 ml 170.36 10 189.29 20 265.00
sodium hyaluronate 0.16% w/v

PRESIDIO TAB 10s 146.57 10 162.86 20 228.00

pregabalin ip 75 ,mg,etoricoxib ip 60 mg

APEX LABORATORIES PVT. LTD.

ACTION-OR PLUS TABLETS 10s 96.43 10 107.14 20 150.00
paracetamol i.p 325 mg,thiocolchicoside 4 mg

CIDIGLIM M1 TABLETS 10s 32.14 10 35.71 20 50.00

metformin hydrochloride i.p. 500 mg,glimepiride ip 1 mg

CIDIGLIM M2 TABLETS 10s 51.43 10 57.14 20 80.00

metformin hydrochloride ip 500 mg,glimepiride ip 2 mg

CADILA PHARMACEUTICALS.
FENTICAD 600MG CAP 1s 63.54 10 70.71 20 99.00
fenticonazole nitrate ph.eur 600 mg

IPCA LABORATORIES LTD.,

BULARID - L TABLETS 10s 80.36 10 89.29 20 125.00
bilastine 20 mg

HYPHORAL CREAM 30 g 135.00 10 150.00 20 210.00

ketoconazole 2% —

IGURATI - 25 TABLET 10s 138.21 10 153.57 20 215.00

iguratimod 25 mg,excipients :q.s. —

PFIZER PRODUCTS INDIA (P) LTD.,

BENEFIX 1000 IU/5 ML INJ 1x5 ml 27,000.00 10 38,095.24 20 50,000.00
nonacogalfa (recombinant coagulation factor-ix) - 1000 iu l-histidine
6.200 mg,glycine ip 78.100 mg,sucrose 40 mg,
polysorbate 80 0.220 mg

BENEFIX 2000 IU/5 ML INJ 1x5ml 54,000.00 10 76,190.00 20 100,000.0

nonacogalfa (recombinant coagulation factor ix) - 2000 iu l-histidine
6.200 mg,glycine ip 78.100 ,g,sucrose 40 mg,
polysorbate 80 0.220 mg

BENEFIX 250IU/5 ML INJ 1x5 ml 6,750.00 10 9,523.81 20 12,500.00

nonacogalfs (recombinant factor ix)- 25o iu l-histidine 6.200
mg,glycine ip 78.100 mg,sucrose 40 mg,polysorbate 80 0.220 mg

TAMILNADU CHEMISTS 24 AUGUST SEPTEMBER 2020

 P.T.S. P.T.R.
Product Pack Rate Margin Rate Margin M.R.P.
% %
BENEFIX 3000 IU/5 ML INJ 1x5 ml 81,000.00 10 114,285.71 20 150,000.00
nonacogalfa (recombinant coagulation factor ix) 3000 iu l-histidine
6.200 mg,glycine ip 78.100 mg,sucrose 40 mg,
polysorbate 80 0.220 mg

BENEFIX 500 IU/5ML INJ. 1x5 ml 13,500.00 10 19,047.62 20 25,000.00

nonacogalfa(recombinant coagulation factor ix)- 500 iu l-histidine
6.200 mg,glycine ip 78.100 mg,sucrose 40 mg,
polysorbate 80 0.220 mg

DACOPLICE 15 MG FCT 1X30 BTLIN(TABLET 1x30 28,607.14 10 31,785.71 20 44,500.00

dacomitinib monohydrate 15 mg

DACOPLICE 30 MG FCT 1X30 BTLIN(TABLET 1x30 39,214.29 10 43,571.43 20 61,000.00

dacomitinib monohydrate 30 mg

DACOPLICE 45 MG FCT 1X30 BTLIN(TABLET 1x30 41,785.71 10 46,428.57 20 65,000.00

dacomitinib monohydrate 45 mg

LORBRIQUA 100 MG FCT 1X30 BTLIN (TAB 1x30 200,571.4 10 222,857.14 20 312,000.00
lorlatinib 100 mg

LORBRIQUA 25 MG FCT 1X30 BTLIN(TABLE 1x30 65,571.43 10 72,857.19 20 102,000.00

lorlatinib 25 mg

RPG LIFE SCIENCES LIMITED.

ALDACTONE T 10 TABLET 10s 51.94 10 57.71 20 80.80
torsemide ip 10 mg,spironolactone 50 mg

ALDACTONE T 5 TABLET 5s 42.04 10 46.71 20 65.40

torsemide ip 5 mg,spironolactone 50 mg

THE HIMALAYA DRUG COMPANY

Q-DEE (IMMUNITY) TABS 8s 18.28 10 20.62 20 30.00
ayurvedic proprietary medicine —

QUISTA ACTIVE 200 G (CF) 200 G 174.06 10 191.10 20 275.00

ayurvedic proprietary medicine 200 g

QUISTA ACTIVE 200 G (MMF) 200 G 174.06 10 191.10 20 275.00

ayurvedic proprietary medicine 200 g

TI BIOTECH LIFESCIENCES
SIGAMIN TABLET 15s 91.52 10 101.70 20 150.00
vitamin b6 2 mg,vitamin c 90 mg,vitamin d 400 iu,vitamin e 10
mg,zinc sulphate monohydrate 12 mg,selenium dioxide 70
mcg,methyi cobalamin 500 mcg,lycopene 5000 mcg

Note : M.R.P. I - Inclusive of All Taxes

Margin - On Selling Price without Tax

For actual product combination, please refer original pack or label.

TAMILNADU CHEMISTS 25 AUGUST SEPTEMBER 2020

 tUªJ»nwh«
âUbešntÈ kht£l« j¢irešÿ® r¡â bko¡fš cÇikahs® âU. ntšKUf‹ mt®fŸ
12.07.2020 m‹W ïiwtdo nr®ªjh®.
âUbešntÈ kht£l«, t©zh®ng£il fÞöÇ bko¡fš cÇikahs® âU. r¡ântš
mt®fŸ 19.02.2020 m‹W ïiwtdo nr®ªjh®.
br§fšg£L kht£l« »H¡F jh«gu« k©ly«, fhkuh#òu«, ghy mãuhÄ bko¡fš
cÇikahs® âU g‹Ù® bršt« mt®fË‹ kfŸ âUkâ nu¡fh mt®fŸ 20.07.2020 m‹W
ïiwtdo nr®ªjh®.
ntÿ® kht£l«, nkš Éõhu«, brs¡fh® fhj® bjU, âU. nf.ã. uÕ¡ mAk¤ mt®fŸ
(Ãô uÕ¡ bko¡fšÞ) 04.08.2020 m‹W ïiwtdo nr®ªjh®.
ÉG¥òu« kht£l« â©otd« jhY¡fh T£nlÇg£L S.S. bko¡fšÞ cÇikahs®
âU. S.S. ghÞf® mt®fŸ 20.08.2020 m‹W ïa‰if vŒâdh®.
â©otd« neUåâÆš cŸs K¤J bko¡fšÞ cÇikahs® âU. V. it¤ÔÞtu‹
mt®fŸ 31.08.2020 m‹W ïa‰if vŒâdh®.

br§fšg£L kht£l kUªJ tÂf® r§f òuty® âU M. gyuhk‹ mt®fŸ

(mÞÉÅ bko¡fšÞ, S.P. nfhÉš) 06.08.2020 m‹W khiy 6 kÂ
msÉš bfhnuhdhthš ghâ¡f¥g£L cÆ® ïHªjh®.

j§fŸ FL«g m§f¤âdiu ïHªJ JaU‰WŸs midtuJ FL«g¤jhU¡F« khÃy,

kht£l r§f¤â‹ rh®ghf ïu§fiy bjÇɤJ¡bfh©L mt®fsJ M‹kh rhªâaila
všyh« tšy ïiwtid ãuh®¤â¡»‹nwh«.

Visit our Website “www.tncda.com”

for updated information

TAMILNADU CHEMISTS 26 AUGUST SEPTEMBER 2020

 átf§if kht£l« njtnfh£il (br‹id) m£tnf£ AR.L.Rªjnur‹ mt®fŸ
ekJ jÄœ ehL kUªJ tÂf®fŸ r§f¤â‰F Mjuthf M‹iy‹ t®¤jf¤â‰F jilia
bgw ngUjÉahf ïUªjh®. mt®fË‹ jhah® âUkâ. Ûdh£á M¢á mt®fŸ 24.08.2020 m‹W«,
nkY« mt®fË‹ jf¥gdh® K‹dhŸ c¢r Úâk‹w jiyik Úâgâ âU.AR.y£Rkz‹ br£oah®
mt®fŸ 27.08.2020 m‹W« ïiwtdo nr®ªjh®fŸ. ïwªj ït®fŸ M‹kh rhªâaila všyh«
tšy ïiwtid ãuh®¤jid brŒ»‹nwh«. jÄœehL kUªJ tÂf®fŸ r§f¤â‹ rh®ghf
Mœªj tU¤j¤ij bjÇɤJ¡bfhŸ»nwh«.

<nuhL bkÆ‹nuhL, FŸs«ghisa«, nfhã âU. K.R. nyhfehj‹ mt®fË‹

jhahU«, (ny£) âU. bfhil¡fhu® uhr¥g fî©lh mt®fË‹ kidÉí«, jÄœehL
kUªJ tÂf® r§f brayhs® âU. K.K. bršt‹ mt®fË‹ gh£oíkhd
âUkâ. R. ïuhkha«khŸ mt®fŸ 16.08.2020 m‹W átnyhf gjÉailªjh®.
m‹dhuJ M‹kh rhªâaila jÄœehL kUªJ tÂf®fŸ r§f« všyh« tšy
ïiwtid ãuh®¤â¤J mŠrÈ brY¤J»wJ.

TAMILNADU CHEMISTS 27 AUGUST SEPTEMBER 2020

 bt‰¿ ÛJ bt‰¿ tªJ e«ik¢ nrU« mij th§»¤
jªj bgUik všyh« e« r§f¤ij¢nrU«;
m‹òilp®! tz¡f«.
thœ¡ifÆš kÅj‹ ca®tj‰F mo¥gil¤ njit fšÉ MF«. mªj tifÆš kUªJ
tÂf®fS¡F¤ njit kUªâaš F¿¤j fšÉ; mjid¡ fU¤âš bfh©L jÄœehL khÃy
kUªJ tÂf®fŸ kht£l r§f K‹ndho cW¥ãd®fŸ, îth»fŸ kht£l« njhW« r§f
cW¥ãd®fËl« e‹bfhil âu£o kUªâaš fšÉ f‰gj‰bfd lh¡l® âU. CL.nk¤jh
mt®fSl‹ ïizªJ mt®fSila e‹bfhiliaí« nr®¤J mt®fŸ jiyikÆš 1974-
M« M©L br‹id Jiu¥gh¡f¤âš uhé› fhªâ rhiyÆš Rkh® 5 V¡f® Ãy¥gu¥ãš ï¡fšÿÇ
ÃWt¥g£lJ. 1979-M« M©L or«g® khj« Kjš njâ kUªJ tÂf®fŸ r§f cW¥ãd®fŸ,
k‰W« mt®fË‹ FHªijfŸ nk«gh£o‰fhf jÄœehL bfÄÞ£ m©£ ou»Þ£ rh®ãš CL.
Baid Metha College of Pharmacy bjhl§f¥g£lJ. âU. CL. bgŒL nk¤jh jiyikÆš ï¡fšÿÇ
1980-M« M©L #&iy 13-M« njâ m‹iwa Rfhjhu¤Jiw mik¢r® kh©òÄF H.V. A©nl
mt®fshš âwªJ it¡f¥g£lJ.
mHFw mik¡f¥g£l ï¡fšÿÆš o.gh®« (D.Pharm) ã.gh®« (B.Pharm) v«.gh®«
(M.Pharm) ã.A¢.o (Ph.D) gh®«-o (Pharm-D) M»a¥ g£l¥go¥òfS« k‰W« üyf trâ,
cztf trâ, j§F« ÉLâ trâ, 60 khzt khzÉfŸ; mku¡Toa msɉF mH»a
fÂ¥bgh¿ tshf« M»a áw¥g«r§fis¡ bfh©l ï¡fšÿÇÆš 750 ¡F« nk‰g£l khzt
khzÉfŸ M©LnjhW« fšÉ gÆ‹W tU»wh®fŸ. jÄœeh£o‹ Äf¢áwªj fšÿÇfËš
ïJî« x‹whf¤ âfœ»wJ.
áw¥òÄ¡f ï¡fšÿÇ ïJtiu âU. CL.nk¤jh mt®fË‹ brašgh£oš ïUªJ tªjJ.
ïjdhš kUªJ tÂf®fsh»a ek¡F beL§fhykhf fšÉ gÆY« thŒ¥ò»il¡fÉšiy. Rkh®
40 M©Lfshf jÄœehL kUªJ tÂf® r§f îthf¡ FG bra‰FGÉš ï¡fšÿÇ g‰¿
ngr¥g£L gy T£l§fŸ el¤â ïWâahf Ô®khd§fŸ Ãiwnt‰w¥g£ld. khÃy r§f
îth»fSl‹ ekJ brayhs® âU.K.K.bršt‹ mt®fŸ jiyikÆš Û£ò elto¡if
nghuh£l« el¤JtJ vd KobtL¡f¥g£lJ. mj‹ gadhf ekJ brayhs®
âU.K.K.bršt‹mt®fŸ jiyikÆš bgU« Ka‰á vL¡f¥g£L gy bgÇat®fis¢ rªâ¤J
ng¢Rth®¤ij el¤â mj‹ _y« CL. Baid Metha College of Pharmacy j‰bghGJ e« tr«
»il¤JŸsJ.
CL. Baid Metha College of Pharmacy Æš nru ÉU«ò« e« r§f cW¥ãd® FHªijfŸ
cÇa É©z¥g got¤ij¥ bg‰W ó®¤â brŒJ m¤Jl‹; kâ¥bg© rh‹¿jœ (Mark
Certificate) kh‰W¢rh‹¿jœ (T.C) k‰W« e« filÆ‹ KftÇ, K¤âiuÆ£L kUªJ cÇk¤â‹
efYl‹ É©z¥ã¡fyh«. fšÉ¡ f£lz« jÉu ntW VJ« »ilahJ.

TAMILNADU CHEMISTS 28 AUGUST SEPTEMBER 2020

 ekJ bgUikÄF m»y ïªâa kUªJ tÂf®fŸ r§f¤â‹ bghUshsU« jÄœehL kUªJ
tÂf® r§f¤â‹ áw¥òÄF brayhsU«, kUªJ tÂf®fË‹ vâ®fhy e«ã¡if e£r¤âukhf¤
âfG« âU. K.K.bršt‹ B.Sc. mt®fŸ bgU« Ka‰á vL¤J ïuî gfš ghuhJ mU«ghLg£L
j‰bghGJ e« bghW¥ãš bfh©L tªJ ïkhyarhjid gil¤JŸsh®. mt®fSl‹ ïizªJ
brašg£l jiyt® âU.K. kndhfu‹ D.Pharm. mt®fŸ, bghUshs® âU. S. ïs§nfht‹
M.Pharm., M.B.A. mt®fŸ k‰W« îth»fS¡F« bra‰FG cW¥ãd®fS¡F« ghuh£Lfisí«
thœ¤J¡fisí« bjÇɤJ¡ bfhŸ»nwh«. tU§fhy¤âš e« tÂf® thÇRfŸ ï§F fšÉ
f‰gjdhš fil el¤j VJthfî« gaDŸsjhfî« ïU¡F«
m©ikÆš xUáy eh£fS¡F K‹ ÉG¥òu« kht£l« kÆy« mU»š cŸs ekJ brhªj
ïl¤âš CL.Baid Metha College of Pharmacy-¡F áw¥ò ói# brŒa¥g£L jÄœehL kUªJ
tÂf®fŸ fšÉ mw¡f£lis¡fhd bga® gyif e« îth»fshš it¡f¥g£LŸsJ v‹gij
k»œ¢ánahL bjÇɤJ¡ bfhŸ»nwh«.
ekJ bgUikÄF brayhs® âU. K.K.bršt‹ B.Sc mt®fŸ RWRW¥ò«, fod ciH¥ò«
JÂî« fLikahd rthšfis mUikahf¢ rªâ¡F« M‰wY« mt‰iw ifahY« âwD«
ekJ T£l§fis xG§fhf áw¥òl‹ el¤J« gh§F« ghuh£l gl nt©oait MF«.
ekJ kUªJ tÂf®fŸ midtU« tU§fhy¤âš tU« rthšfis M‹iy‹ kUªJ
t®¤jf¤ij jil brŒâl e« bjhÊiy ghJfh¡f cÆ®fh¡F« c‹dj kUªJfis F¿¥ã£l
xnu ÉiyÆš ɉgid brŒnth«. jŸSgo ɉgid¡F K‰W¥òŸË it¥ngh«. r§f¤â‹
tÊ el¥ngh«. x‹Wg£L brašgLnth«.
thœf itaf«! ts®f kUªJ tÂf® ey‹! X§Ff mt®j« òfœ !

TAMILNADU CHEMISTS 29 AUGUST SEPTEMBER 2020